The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer

Objective: To analysis breast cancer sentinel lymph channels (SLCs) and the shape of the sentinel lymph nodes (SLNs) perfusion by contrast-enhanced ultrasound (CEUS) and to explore its value in the diagnosis of sentinel metastasis lymph nodes. Methods: A retrospective analysis, 66 breast cancer pati...

Full description

Bibliographic Details
Main Author: Ping Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM
Format: Article
Language:English
Published: Editorial Office of Advanced Ultrasound in Diagnosis and Therapy 2018-08-01
Series:Advanced Ultrasound in Diagnosis and Therapy
Subjects:
Online Access:http://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/1534732215274-1985650208.pdf
_version_ 1829137829246009344
author Ping Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM
author_facet Ping Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM
author_sort Ping Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM
collection DOAJ
description Objective: To analysis breast cancer sentinel lymph channels (SLCs) and the shape of the sentinel lymph nodes (SLNs) perfusion by contrast-enhanced ultrasound (CEUS) and to explore its value in the diagnosis of sentinel metastasis lymph nodes. Methods: A retrospective analysis, 66 breast cancer patients with 101 ipsilateral axillary SLNs checking by CEUS, was confirmed by pathology. SLCs and SLNs positions were marked and then the rough needle biopsy pathology was used to confirm the benign or malignant SLNs. According to the different perfusion, SLNs were divided into five groups and evaluated by scores. MecNemar test and receiver operating characteristic (ROC) curve were used to analyze the statistical analysis. The difference of p < 0.05 was statistically significant. The cut-off value was finally determined, and the results of ultrasound screening test were evaluated. Results: A total of 66 patients with 101 SLNs were successfully evaluated, including 42 cases of metastatic lymph nodes, and 59 cases of benign lymph nodes. The area under the ROC curve was 0.752 (p < 0.05). To ROC curve, the cut off value was 3.5. The scores 4 and 5 of lymph nodes were negative, and scores 1, 2, 3 of lymph nodes were positive. The sensitivity, specificity, false negative rate, false positive rate, and the coincidence rate of the screening test were 44.19%, 93.10%, 55.81%, 6.9%, 72.28% respectively. The value of positive predictive and the negative predictive were 82.61%, 69.23% respectively. Conclusion: To evaluate SLCs shape and judge benign and malignant SLNs, percutaneous CEUS has a high practical value.
first_indexed 2024-12-14T19:05:13Z
format Article
id doaj.art-5187297ccb6746fca717bfa7f922cfc2
institution Directory Open Access Journal
issn 2576-2516
language English
last_indexed 2024-12-14T19:05:13Z
publishDate 2018-08-01
publisher Editorial Office of Advanced Ultrasound in Diagnosis and Therapy
record_format Article
series Advanced Ultrasound in Diagnosis and Therapy
spelling doaj.art-5187297ccb6746fca717bfa7f922cfc22022-12-21T22:50:52ZengEditorial Office of Advanced Ultrasound in Diagnosis and TherapyAdvanced Ultrasound in Diagnosis and Therapy2576-25162018-08-012211311810.37015/AUDT.2018.180808The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast CancerPing Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM0Department of Ultrasound, The Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaObjective: To analysis breast cancer sentinel lymph channels (SLCs) and the shape of the sentinel lymph nodes (SLNs) perfusion by contrast-enhanced ultrasound (CEUS) and to explore its value in the diagnosis of sentinel metastasis lymph nodes. Methods: A retrospective analysis, 66 breast cancer patients with 101 ipsilateral axillary SLNs checking by CEUS, was confirmed by pathology. SLCs and SLNs positions were marked and then the rough needle biopsy pathology was used to confirm the benign or malignant SLNs. According to the different perfusion, SLNs were divided into five groups and evaluated by scores. MecNemar test and receiver operating characteristic (ROC) curve were used to analyze the statistical analysis. The difference of p < 0.05 was statistically significant. The cut-off value was finally determined, and the results of ultrasound screening test were evaluated. Results: A total of 66 patients with 101 SLNs were successfully evaluated, including 42 cases of metastatic lymph nodes, and 59 cases of benign lymph nodes. The area under the ROC curve was 0.752 (p < 0.05). To ROC curve, the cut off value was 3.5. The scores 4 and 5 of lymph nodes were negative, and scores 1, 2, 3 of lymph nodes were positive. The sensitivity, specificity, false negative rate, false positive rate, and the coincidence rate of the screening test were 44.19%, 93.10%, 55.81%, 6.9%, 72.28% respectively. The value of positive predictive and the negative predictive were 82.61%, 69.23% respectively. Conclusion: To evaluate SLCs shape and judge benign and malignant SLNs, percutaneous CEUS has a high practical value.http://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/1534732215274-1985650208.pdf|breast cancer|contrast ultrasound|slns|needle biopsy
spellingShingle Ping Wang, MM, Jian Liu, MD, Wensheng Yue, MM, Wenyan Li, MM, Yuqun Luo, MM, Jiao He, MM
The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
Advanced Ultrasound in Diagnosis and Therapy
|breast cancer|contrast ultrasound|slns|needle biopsy
title The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
title_full The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
title_fullStr The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
title_full_unstemmed The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
title_short The Value of Percutaneous Contrast-Enhanced Ultrasound in the Evaluation of Sentinel Lymph Node of Breast Cancer
title_sort value of percutaneous contrast enhanced ultrasound in the evaluation of sentinel lymph node of breast cancer
topic |breast cancer|contrast ultrasound|slns|needle biopsy
url http://www.journaladvancedultrasound.com:81/fileup/2576-2516/PDF/1534732215274-1985650208.pdf
work_keys_str_mv AT pingwangmmjianliumdwenshengyuemmwenyanlimmyuqunluommjiaohemm thevalueofpercutaneouscontrastenhancedultrasoundintheevaluationofsentinellymphnodeofbreastcancer
AT pingwangmmjianliumdwenshengyuemmwenyanlimmyuqunluommjiaohemm valueofpercutaneouscontrastenhancedultrasoundintheevaluationofsentinellymphnodeofbreastcancer